The purpose of this trial is to identify a dose or doses of INS50589 intravenous infusion that are well-tolerated and which reduce postoperative bleeding and blood product transfusion.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Enrollment
160
Postoperative chest drainage volume
Requirement for perioperative blood product transfusion
Incidence of complications after surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Baptist Medical Center Princeton
Birmingham, Alabama, United States
Cardiology, P.C.
Birmingham, Alabama, United States
Sharp Memorial Hospital
San Diego, California, United States
Memorial Medical Center
Springfield, Illinois, United States
St. John's Hospital
Springfield, Illinois, United States
Southern Illinois University School of Medicine
Springfield, Illinois, United States
Lutheran Hospital of Indiana
Fort Wayne, Indiana, United States
Veterans Affairs Medical Center
Lexington, Kentucky, United States
University of Kentucky, Chandler Medical Center
Lexington, Kentucky, United States
St. Mary's of Michigan
Saginaw, Michigan, United States
...and 17 more locations